Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Solid Biosciences LLC stock
Learn how to easily invest in Solid Biosciences LLC stock.
Solid Biosciences LLC is a biotechnology business based in the US. Solid Biosciences LLC shares (SLDB) are listed on the NASDAQ and all prices are listed in US Dollars. Solid Biosciences LLC employs 104 staff and has a trailing 12-month revenue of around $14.8 million.
How to buy shares in Solid Biosciences LLC
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SLDB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Solid Biosciences LLC stock price (NASDAQ: SLDB)Use our graph to track the performance of SLDB stocks over time.
Solid Biosciences LLC shares at a glance
|Latest market close||$0.51|
|52-week range||$0.42 - $3.36|
|50-day moving average||$0.71|
|200-day moving average||$0.96|
|Wall St. target price||$5.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.72|
Buy Solid Biosciences LLC shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Solid Biosciences LLC stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Solid Biosciences LLC price performance over time
|1 week (2022-09-19)||-11.64%|
|1 month (2022-08-26)||-29.75%|
|3 months (2022-06-24)||-12.01%|
|6 months (2022-03-25)||-58.96%|
|1 year (2021-09-24)||-80.79%|
|2 years (2020-09-25)||-75.69%|
|3 years (2019-09-26)||10.38|
|5 years (2017-09-22)||N/A|
Solid Biosciences LLC financials
|Revenue TTM||$14.8 million|
|Gross profit TTM||$13.6 million|
|Return on assets TTM||-22.64%|
|Return on equity TTM||-43.49%|
|Market capitalisation||$65.6 million|
TTM: trailing 12 months
Solid Biosciences LLC share dividends
We're not expecting Solid Biosciences LLC to pay a dividend over the next 12 months.
Solid Biosciences LLC share price volatility
Over the last 12 months, Solid Biosciences LLC's shares have ranged in value from as little as $0.42 up to $3.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Solid Biosciences LLC's is 1.3718. This would suggest that Solid Biosciences LLC's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Solid Biosciences LLC overview
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc.
Frequently asked questionsWhat percentage of Solid Biosciences LLC is owned by insiders or institutions?
Currently 9.434% of Solid Biosciences LLC shares are held by insiders and 59.93% by institutions. How many people work for Solid Biosciences LLC?
Latest data suggests 104 work at Solid Biosciences LLC. When does the fiscal year end for Solid Biosciences LLC?
Solid Biosciences LLC's fiscal year ends in December. Where is Solid Biosciences LLC based?
Solid Biosciences LLC's address is: 141 Portland Street, Cambridge, MA, United States, 02139 What is Solid Biosciences LLC's ISIN number?
Solid Biosciences LLC's international securities identification number is: US83422E1055 What is Solid Biosciences LLC's CUSIP number?
Solid Biosciences LLC's Committee on Uniform Securities Identification Procedures number is: 83422E105
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert